Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Trisomy | Research

Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication

Authors: Weifang Tian, Yangyang Yuan, Erfeng Yuan, Linlin Zhang, Ling Liu, Ying Li, Jing Guo, Xueyin Cui, Pengyun Li, Shihong Cui

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background

With the development of whole-genome sequencing technology, non-invasive prenatal testing (NIPT) has been applied gradually to screen chromosomal microdeletions and microduplications that cannot be detected by traditional karyotyping. However, in NIPT, some false positives and false negatives occur. This study aimed to investigate the applicability of extended NIPT (NIPT-PLUS) in the detection of chromosomal aneuploidy and microdeletion/microduplication syndrome (MMS).

Methods

A total of 452 pregnancies that underwent prenatal diagnostic testing (amniocentesis or chorionic villus sampling) by chromosomal microarray analysis (CMA), were screened by NIPT-PLUS from the peripheral blood sample of the pregnant women. The results of the two tested items were compared and analysed.

Results

Of the 452 cases, 335 (74.12%) had positive CMA results, and 117 (25.88%) had no abnormal results. A total of 86 cases of trisomy 21, 18 and 13 and sex chromosome aneuploidy (SCA) were detected by CMA and NIPT-PLUS, with a detection rate of 96.51% (83/86). Among them, the detection rates of T18, T13; 47, XXY; 47, XXX and 47 XYY were 100%, and the detection rates of T21 and 45 XO were 96.55% and 90%, respectively. The detection sensitivity of rare chromosomal trisomy (RAT) was 80% (4/5). The positive predictive values of NIPT-PLUS for chromosome aneuploidy T21, T18 and T13 and for SCA and RAT were 90.32%, 87.50%, 25.00%, 88.89% and 50%, respectively. A total of 249 cases (74.32%) of chromosomal MMS were detected by CMA. The detection rate of NIPT-PLUS was 63.86% (159/249), and 90 cases (36.14%) were missed. The larger the MMS fragment, the higher the NIPT-PLUS detection sensitivity. In addition, most small fragments were of maternal origin.

Conclusion

The comparison between the CMA and NIPT-PLUS techniques shows that NIPT-PLUS has high sensitivity for detecting chromosomal aneuploidy and chromosomal copy number variations (CNVs) with fragments > 5 M. However, the sensitivity of CNV for fragments < 5 M is low, and the missed detection rate is high. Additionally, confined placental mosaicism and foetal mosaicism are the key factors causing false negatives in NIPT-PLUS, while maternal chromosomal abnormalities and confined placental mosaicism are key contributors to false positives, so appropriate genetic counselling is especially important for pregnant women before and after NIPT-PLUS testing.
Literature
15.
16.
go back to reference Riggs ER, Andersen EF, Cherry EM, Kantarci S, Kearney H, Patel A, et al. Correction: Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2021;23(11):2230. https://doi.org/10.1038/s41436-021-01150-9.CrossRefPubMed Riggs ER, Andersen EF, Cherry EM, Kantarci S, Kearney H, Patel A, et al. Correction: Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2021;23(11):2230. https://​doi.​org/​10.​1038/​s41436-021-01150-9.CrossRefPubMed
18.
go back to reference Jie W, Xiaoping J, Liqiong W, et al. Analysis of influencing factors of fetal free DNA ratio in non-invasive prenatal screening. Int J Lab Med. 2021;42(02):146–50. Jie W, Xiaoping J, Liqiong W, et al. Analysis of influencing factors of fetal free DNA ratio in non-invasive prenatal screening. Int J Lab Med. 2021;42(02):146–50.
Metadata
Title
Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication
Authors
Weifang Tian
Yangyang Yuan
Erfeng Yuan
Linlin Zhang
Ling Liu
Ying Li
Jing Guo
Xueyin Cui
Pengyun Li
Shihong Cui
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01285-2

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue